Anti-PI 3 Kinase catalytic subunit alpha/PIK3CA antibody [EPR19693] and 4 more items

Epitomics Inc has been awarded a contract by the University of Virginia effective September 1, 2026, with a cumulative value of $2,499.75. The contract is classified under Virginia (VA) procurement authority. The awardee will deliver specialized research materials to Andrew Jason Nafziger at the University of Virginia.

The contract encompasses the supply of five research reagent line items, consisting primarily of monoclonal antibodies targeting phosphatidylinositol 3-kinase (PI3K) pathway proteins and an associated assay kit. Specific deliverables include anti-PI 3-kinase catalytic subunit alpha antibody (unit price: $514.80), anti-PI 3-kinase catalytic subunit gamma antibody (unit price: $519.75), anti-PI3-kinase p110 delta antibody (unit price: $554.40), anti-PI3-kinase p110 beta antibody (unit price: $584.10), and one Cellular Reactive Oxygen Species Assay Kit in Red formulation (unit price: $326.70). Each line item is specified as a single-unit purchase delivered to the designated recipient.